Bio-Rad Reads: Droplet Digital PCR World 2024 Edition

Welcome to Bio-Rad Reads: ddPCR World 2024 Edition! This month we’re bringing you a sneak peek into some of the exciting programming ddPCR World 2024 has to offer.

ddPCR World 2024 is the premier live virtual gathering that brings together leading scientists and experts from around the world who are driving cutting-edge research powered by Droplet Digital? PCR (ddPCR?) technology. This free event takes place June 4th-5th and features presentations showcasing the power of ddPCR technology across a wide spectrum of applications, from cell and gene therapy manufacturing to public health wastewater surveillance. ?

In this newsletter, we’ll spotlight some of this year’s impressive presenters and the exciting research they’ll be sharing at ddPCR World 2024 .

The unmatched sensitivity, precision, and absolute quantification capabilities of ddPCR technology make it an indispensable tool for clinical oncology researchers. To learn more about how ddPCR is redefining possibilities in cancer screening, non-invasive liquid biopsy, precision oncology diagnostics, and beyond, check out these presentations:

• Moving Towards the Clinical Implementation of Circulating Tumor DNA Analysis in Advanced Breast Cancer - Dr. Isaac Garcia-Murillas, Breast Cancer Now Research Centre, The Institute of Cancer Research, London
• Droplet Digital PCR: ctDNA Detection Through Promotor-Hypermethylation - Anna Ennemoser, Innsbruck Austria
• Identification of Prognostic and Predictive Biomarkers in r/r B-NHL Patients Treated with CD19.CAR-T Cell Therapy – Prof. Manuela Ferracin, University of Bologna, Bologna

?ddPCR technology also supports biopharma users in every step of cell and gene therapy development and manufacturing, from viral vector characterization to lot release testing and post-treatment patient monitoring. Discover how accurate and reliable ddPCR-based solutions are helping cell and gene therapy developers break new ground by registering for these sessions:

• ?ddPCR to Characterize Production Clones in Early Phases of Biomanufacturing - Dr. Katia Cantalupo, Associate Scientist, Molecular Biology Technologies & Innovation, Healthcare Division, Merck
• CAR-T Cell Safety Concerns and Vector Copy Number Determination by ddPCR - Dr. David Cobeta, Scientist at Charles River Laboratories – Leiden
• Empty/Full rAAV Capsid Characterization: Quantifying Viral Genome and Capsid Titers in a Single ddPCR Reaction - Tyler Lindgren, Associate Scientist, BridgeBio Gene Therapy

?Explore the pivotal role of ddPCR technology in wastewater-based epidemiology (WBE). WBE offers insights into community-wide temporal trends in infectious disease and provides near real-time data, all without the need for individual participation or approval. Leveraging ddPCR's advantages, such as fast analysis time, absolute quantification, and sensitivity to detect low copy numbers, enhances WBE monitoring capabilities and offers invaluable insights for public health management. Attend these sessions to learn more about how experts are proactively monitoring the detection of pathogens to alert public health officials to outbreaks and limit the spread of disease:

• Development of an Assay for Respiratory Pathogens on the QX600 for Wastewater-based Epidemiology – Dr. Kyle McElroy, Scientist, Biobot Analytics
• Using ddPCR to Detect Emerging and Endemic Pathogens in Wastewater – Dr. Bradley White, Director, Verily (Google) Life Sciences

?Don’t miss out on these and other exciting presentations from global research leaders who are leveraging Droplet Digital PCR technology to advance discovery and drive biomedical innovation. Select a regional track that fits your schedule or attend both regional tracks — register today to secure your spot: Droplet Digital PCR World 2024 .